not vested
Summary of Latest Ratings, TPs, Views on GALAXY ENT from Major BrokersBrokers | Ratings | TPs (HKD) | Core Views
Related News HSBC Research: Macau Avg Daily GGR in First 10 Days of May Flat; Bullish on SANDS CHINA LTD (01928.HK), GALAXY ENT (00027.HK) and MGM CHINA (02282.HK)
Goldman Sachs | Buy | 53.2 | 1Q results met expectations. Market share in GGR rebounded in April and May. Dividend level provides downside support for the share price.
HSBC Research | Buy | 48.5 | 1Q margin beat. The company defended market share through precise marketing strategies while maintaining cost discipline. Continued growth of Capella at Galaxy Macau and Horizon Plus in Macau will support EBITDA growth this year.
CLSA | Outperform | 47.4 | Results met expectations. Net cash reached as high as USD4.67 billion, with capex expected to peak in 2026.
Related News UBS: GALAXY ENT (00027.HK), WYNN MACAU (01128.HK) Gain GGR Market Share in April
UBS | Buy | 46 | 1Q adjusted EBITDA met expectations. EBITDA margin improved after adjusting for win rate. Although the World Cup may affect short-term traffic, the company arranged events in response.
Morgan Stanley | Equalweight | 39 | 1Q results met expectations. Operating expenses remained disciplined.
Citi | Buy | 52 | 1Q results met expectations. Core gaming business EBITDA still recorded YoY growth. Both mass and VIP GGR increased.
Source: AASTOCKS Financial News
http://www.aastocks.com/en/stocks/news/ ... -news/AAFN
It's all about "how much you made when you were right" & "how little you lost when you were wrong"